NCT03017521View on ClinicalTrials.gov

K-BASKET, TAS-117, PI3K/AKT Gene Aberration

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Solid Tumor, Adult
Interventions
DRUG

TAS-117

TAS-117 16mg, daily

Trial Locations (1)

03722

Severance Hospital, Yonsei University Health System, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03017521 - K-BASKET, TAS-117, PI3K/AKT Gene Aberration | Biotech Hunter | Biotech Hunter